Medical device company, St. Jude Medical Inc. (STJ), recently enrolled the first patient in the STAR-VT (Substrate Targeted Ablation using the FlexAbility Ablation Catheter System for the Reduction of Ventricular Tachycardia) clinical trial.
from Content Keyword RSS http://ift.tt/1w3Ymd6
via IFTTT
from Content Keyword RSS http://ift.tt/1w3Ymd6
via IFTTT
No comments:
Post a Comment